Cargando…

Editorial overview: Antivirals and resistance: Advances and challenges ahead

Detalles Bibliográficos
Autores principales: Menéndez-Arias, Luis, Richman, Douglas D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129102/
https://www.ncbi.nlm.nih.gov/pubmed/25155454
http://dx.doi.org/10.1016/j.coviro.2014.08.002
_version_ 1783516712222588928
author Menéndez-Arias, Luis
Richman, Douglas D
author_facet Menéndez-Arias, Luis
Richman, Douglas D
author_sort Menéndez-Arias, Luis
collection PubMed
description
format Online
Article
Text
id pubmed-7129102
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71291022020-04-08 Editorial overview: Antivirals and resistance: Advances and challenges ahead Menéndez-Arias, Luis Richman, Douglas D Curr Opin Virol Article Published by Elsevier B.V. 2014-10 2014-08-22 /pmc/articles/PMC7129102/ /pubmed/25155454 http://dx.doi.org/10.1016/j.coviro.2014.08.002 Text en Copyright © 2014 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Menéndez-Arias, Luis
Richman, Douglas D
Editorial overview: Antivirals and resistance: Advances and challenges ahead
title Editorial overview: Antivirals and resistance: Advances and challenges ahead
title_full Editorial overview: Antivirals and resistance: Advances and challenges ahead
title_fullStr Editorial overview: Antivirals and resistance: Advances and challenges ahead
title_full_unstemmed Editorial overview: Antivirals and resistance: Advances and challenges ahead
title_short Editorial overview: Antivirals and resistance: Advances and challenges ahead
title_sort editorial overview: antivirals and resistance: advances and challenges ahead
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129102/
https://www.ncbi.nlm.nih.gov/pubmed/25155454
http://dx.doi.org/10.1016/j.coviro.2014.08.002
work_keys_str_mv AT menendezariasluis editorialoverviewantiviralsandresistanceadvancesandchallengesahead
AT richmandouglasd editorialoverviewantiviralsandresistanceadvancesandchallengesahead